Clinical Development Of Biosimilars

This track includes Clinical trials on major diseases Risk management, and quality affairs, Case studies, and clinical models, Transgenic animals, Targeted cell line development, Clinical biosimilar tracks.docx PK/PD studies, Toxicological studies and Aspects of genotoxicity tests.Clinical trials are designed in stages I-IV so as to receive a clear picture of the drug candidate in respect to its pharmacokinetics and pharmacodynamics parameters.

Biologics also represent over 40 percent of the drugs in each of the preclinical, Phase I, Phase II, and Phase III trial stages.

  • Biosimilars Clinical Trials
  • Toxicological studies
  • Clinical PK/PD studies
  • Targeted cell line development
  • Transgenic animals
  • Case studies, and clinical models
  • Risk management, and quality affairs
  • Clinical trials on major diseases
  • Biosimilars Clinical Studies
  • Aspects of genotoxicity tests

Related Conference of Clinical Development Of Biosimilars

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Clinical Development Of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in